DealsOct 29, 2026, 07:41 AM
Virax Biolabs Signs 3 China Distributors for Immune Profiling Products
AI Summary
Virax Biolabs Group Ltd. announced that its China subsidiary, Shanghai Xitu Consulting Co., Ltd., has entered into non-exclusive distribution agreements with three Chinese companies: AmyJet Scientific Inc., Jiangsu Real-Gen Biotechnology Co., Ltd., and Zhixi (Shanghai) Biotechnology Co., Ltd. These agreements are for Virax's ImmuneSelect research-use immune profiling products and establish distribution routes across six mainland Chinese markets, including major biotech hubs. The distributors will handle local sales and customer engagement, while Virax will provide product supply and technical support. This strategy aims to expand commercial reach in China efficiently.
Key Highlights
- Virax Biolabs enters non-exclusive distribution agreements with AmyJet Scientific, Jiangsu Real-Gen Biotechnology, and Zhixi (Shanghai) Biotechnology.
- Agreements cover ImmuneSelect research-use immune profiling products in six mainland Chinese markets.
- AmyJet will target industrial and biotechnology customers in Beijing, Shanghai, and Hubei.
- Jiangsu Real-Gen will target academic, biopharmaceutical, and research customers in Jiangsu, Anhui, and Shandong.
- Zhixi adds a targeted Shanghai academic sales channel.
- Initial product focus includes ELISpot assay plates and antigen-specific peptide pools for infectious disease, vaccine, and cellular immunity research.
Price Impact
More from VRAX